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Acute  streptococcal  gingivitis  is  an  acute 
inflammation of the oral mucosa and the pathogens 
implicated  in  gingival  inflammation  is  rarely 
different from that of routine plaque-associated 
gingivitis such as Neisseria gonorrhea, Treponema 
pallidum  and  recently  streptococci  infections.1,2 
Streptococci, which can be seen in the composition of 
microbial dental plaque, may cause inflammatory 
periodontal  disease  and  dental  caries.3  During 
the  International  Workshop  for  a  Classification 
of Periodontal Disease and Conditions in 1999, a 
new classification of disease was introduced and 
American Periodontology Academy classified the 
streptococcal periodontal disease under the group 
of gingival disease due to this specific bacterium 
has poor related with microbial plaque formation. 
Although  the  streptococci  related  disease  of 
gingiva has very specific microbiological and clinic 
features, there have been only a few cases reported 
in  the  literature.  Another  significant  feature  of 
streptococcal gingivitis is that, it can be seen on 
gingiva with the other inflammatory diseases like 
throat inflammations.4,5 However, the previous data 
about the combination of streptococcal gingivitis 
and  other  periodontal  diseases  as  aggressive 
periodontitis (AP) is unclear.
The purpose of this case report was two-fold; 
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AbSTRACT 
Acute streptococcal gingivitis is an acute inflammation of the oral mucosa and also may be seen 
with the other oral diseases as aggressive periodontitis that is characterized by a considerable 
attachment loss over a relatively short period of time. Streptococcal infections of gingiva are seen 
rarely; also the origin of this gingival inflammation is occasionally different from that of routine 
plaque-associated gingivitis. The clinical features and treatment methods of these diseases are 
already reported in previous literatures. This case report describes a patient who presented with 
severe gingival inflammation and attachment loss that was diagnosed as an acute streptococcal 
infection  associated  with  aggressive  periodontitis.  In  this  study  a  supportive  treatment  option 
was demonstrated based on these data and antacid treatment as adjunctive to the recommended 
treatment modalities was used for streptococcal gingivitis. (Eur J Dent 2007;1:251-255)
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first,  to  show  how  streptococcal  infections  can 
be effective to cause severe periodontal damage 
in AP and second, to test a supportive treatment 
modality  which  may  be  very  effective  to  this 
devastating condition.
CASE REPORT
The  patient,  a  26-year-old  female,  was 
referred to our clinic by her general dentist for 
severe bleeding gums, gingival hyperplasia, and 
halitosis. At the time, the patient was experiencing 
pain, severe bleeding with brushing related to her 
periodontal disease. She had a non-contributory 
medical  history.  However,  prior  to  her  visit  to 
our  clinic,  she  had  never  had  a  periodontal 
examination.  On  examination,  generalized 
edematous,  hyperplastic  gingiva,  bleeding  on 
probing and calculus formation was seen (Figure 
1).  To  determine  the  clinical  situation  of  the 
subject, gingival index,6 plaque index,7 periodontal 
probing  depths  (PPD)  and  clinical  attachment 
levels (CAL) of the teeth were recorded before and 
after the treatment by using a manual probe (Hu-
Friedy Manufacturing Inc., Chicago, IL, USA) (Table 
1).  Periodontal  examination  revealed  gingival 
swelling, 78.2% bleeding at probing sites, 52.7% 
plaque control record, and 72.9% of the sites had 
a periodontal pocket depth of 4 mm or more. Upon 
initial  examination,  radiographs  demonstrated 
extensive generalized vertical intra-bony defects 
in the maxillary and mandibular arches (Figure 2).   
Based on the clinical and radiographic findings, 
a diagnosis of generalize AP was assigned to the 
patient.  According  to  these  findings,  treatment 
was started with an initial phase of mechanical 
therapy; including systematic scaling and planing 
of all accessible root surfaces and the introduction 
of meticulous oral hygiene. During oral hygiene 
instruction and subsequent initial preparation as a 
chemotherapeutic support tetracycline (only first 
day 2 x 100mg and 1 x 100mg/day – Tetradox, Fako, 
Turkey) had been given to the patient with a mouth 
rinse including Chlorhexidine Digluconate (0.12%) 
and Benzidamin HCL (0.15%) (Kloroben, Drogsan, 
Turkey).  And  also  to  improve  the  patient’s  oral 
and  dental  hygiene,  a  new  soft  toothbrush  was 
referred for use as part of the oral care protocol. 
After  optimal  oral  hygiene  was  provided,  based 
on  persistence  of  periodontal  lesions,  a  second 
phase of therapy was planned and the advanced 
periodontal  therapy,  flap  and  gingivectomy 
operations were done and remaining roots were 
  T0 T1 T2 T3
PI 2.34 0.67 0.51 0.18
GI 2.81 0.95 0.35 0.05
PPD 6.41 5.13 4.09 4.01
CAL 4.96 4.85 4.05 3.91
PI, Plaque Index; GI, Gingival Index; PPD, Periodontal Probing Depths;  CAL, Clinical Attachment Levels.
Table 1. Clinical parameters of patient assessed at baseline (T0), after initial treatment (T1), after 
periodontal surgery (T2) and after the all periodontal treatments (T3).
Figure 1. Pre-treatment clinical view of anterior 
region of the oral cavity showing severe gingival 
inflammation  diffused  periodontal  and  gingival 
abscess formation.
Figure  2.  Panoramic  radiograph  showing 
generalize  bone  loss;  especially  at  the  molar 
areas.
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removed.  After  resolution  of  the  periodontal 
infection (a period of seven weeks), the patient was 
placed on an individually tailored maintenance care 
program  including  continuous  evaluation  of  the 
occurrence and the risk of disease progression. 
However, after a week, bleeding, edema and dark 
red discoloration on the marginal areas of gingiva 
developed again (Figure 3). Further medical tests 
were carried out to look for searching an underlying 
systemic disease and its impact on the etiology 
of  the  disease.  Because  of  the  results  were  in 
normal limits, we suspected acute streptococcal 
infection. Although acute streptococcal infection 
was  suspected  because  of  the  clinical  features 
of  the  patient,  for  being  sure  bacterial  sample 
was  obtained  by  scraping  the  surfaces  of  the 
gingival  lesions  with  a  sterile  chip  and  the 
anaerobic-culture technique were used to identify 
the  bacteria.  Cultures  of  the  gingival  samples 
grew  streptococcus  pyogenes  and  a  few  other 
microorganisms. To prevent antibiotic resistance 
development  with  chemotherapeutic  agents  in 
the  treatment  of  aggressive  periodontitis,  we 
decided to use an alternative treatment primarily, 
which was based on the microorganism’s growth 
characteristics.  The  acidic  oral  pH  required  for 
growing of the Streptococcus species was tried to 
change and the optimal oral pH in normal values 
was kept. For this purpose, an antacid chewing 
tablet  (Rennie  680mg,  Roche,  Turkey),  which 
includes calcium and magnesium carbonate, was 
offered two times a day for a week. To determine 
the effectiveness of this medication, normal whole 
saliva  pH  and  whole  saliva  pH  after  using  the 
antacid were measured (Inolab pH meter level 2, 
Wissenschafllich  Technische,  Germany)  (Figure 
4). This normal value was picked up of the same 
patient in different moments. At the end of this 
additional  treatment,  oral  health  was  obtained 
(Figure 5).
DISCuSSION
In a revised classification system for periodontal 
diseases, AP was redefined to comprise a complex 
entity  of  microbial  alterations  and  cellular 
dysfunctions  that  differentiate  the  underlying 
molecular mechanisms from chronic periodontal 
disease.8  The  aggressive  nature  of  this  disease 
process is due in part to A. actinomycetemcomitans, 
which  is  regarded  as  the  key  etiological  agent 
based  on  studies  reporting  a  frequency  rate  of 
nearly  90%  in  periodontal  lesions.9  There  is  a 
consensus about the method and application of the 
treatment for AP. Once AP has been diagnosed, 
a  comprehensive  periodontal  treatment  plan 
must be developed. The treatment of periodontal 
diseases  is  divided  into  four  phases:  systemic, 
hygienic, corrective and maintenance / supportive 
therapy.  As  treatment  progresses  through  the 
four phases, the dentist uses both surgical and 
non-surgical  therapy  to  remove  biofilm  created 
by the bacterial pathogens; this procedure is in 
agreement  with  good  medical  practice  because 
the  bacterial  load  should  be  reduced  as  much 
as  possible  prior  to  the  use  of  antibiotics.  The 
adjunctive  systemic  use  of  antimicrobials  along 
Figure 3. Clinical view of anterior region of the 
oral  cavity  after  the  treatment  for  aggressive 
periodontitis  showing  acute  streptococcal 
gingivitis.
Figure 4. PH values of normal and with antacid 
administration saliva samples.
1st sample:  Without any intervention.
2nd sample:  5 minutes after oral antiacid administration.
3rd sample: 30 minutes after oral antiacid administration.
4th sample:  60 minutes after oral antiacid administration.
5th sample:  6 hours after oral antiacid administration.
6th sample:  6.5 hours after oral antiacid administration.
7th sample:  After using the antacid two times a day for one week.
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with mechanical debridement of the root surfaces 
to disrupt the biofilm is effective in most patients 
with AP.10
Tetracycline  that  was  used  by  most  of  the 
researchers  in  previous  studies  was  chosen 
for  chemotherapy  because  of  its  affectivity  for 
periodontal diseases and high secretion capacity 
from gingival tissue.11 The patient was also treated 
according to these recommendations. Although a 
successful and appropriate treatment was applied 
to the patient according to the recommendations 
for AP, streptococcal inflammation increased the 
worsening of the oral findings present in AP.
Acute streptococcal gingivitis has been given 
little attention in the dental literature in general, 
and in the periodontal literature in particular. Only 
one well-documented study is cited in the medico-
dental  literature.4  The  treatment  of  choice  for 
streptococci infections is penicillin. Sulfonamides 
and  broad  spectrum  antibiotics  have  also  been 
used to treat streptococcal infections. Recognition, 
identification of etiology, diagnosis of disease, and 
treatment of acute gingivostomatitis are critically 
important  of  untreated  group  A  beta-hemolytic 
streptococcal infection, which has many serious 
complications.12
In  addition  to  this  primary  etiologic  factor, 
other  factors  such  as  differentiation  of  saliva 
composition can foster progression of this disease.   
In progression of this disease like other periodontal 
diseases, saliva plays important roles as a disease 
marker and as a defense mechanism.
Saliva has some antimicrobial activity against 
many  different  microorganisms.  This  is  mainly 
due to the presence of immunoglobulin and non-
immunoglobulin  agents  in  its  content.13  It  also 
prevents the proteins and cells in oral mucosa from 
H2O2 toxicity.14 At physiologic concentrations and 
neutral pH, it prevents the bacterial glycolysis by 
inhibiting the pH and potentiates the antibacterial 
defense mechanisms as a bacteriostatic agent.15,16 
It has been shown that the OHSCN/ OSCN value 
had  a  stronger  anti-streptococcal  effect  and 
inhibited  the  bacterial  growth  very  effectively  if 
it  was  sufficiently  present  enough  in  the  saliva 
in  pH  values  of  7.17  The  pH  of  saliva  increases 
with  concomitant  secretion  of  HCO3  with  saliva 
secretion (5.5-7.5). The most important factor for 
the increase of the pH is the HCO3.18 Even though 
saliva  has  all  those  beneficiary  antimicrobial 
effects that were mentioned above, sometimes it 
may not be sufficient enough to kill some specific 
bacteria which can be available in oral pH values 
of 6-8 and for streptococcus species which can 
survive  at  a  low  pH  and  to  continue  producing 
acid. In conclusion, using an antacid agent may 
prove to be useful as an indicator of environmental 
conditions in the oral cavity, and as a determinant 
of treatment model among oral streptococci.
         
CONCLuSIONS
With this case report an alternative treatment 
option based on these data was demonstrated and 
antacid  treatment  as  adjunctive  to  the  recommended 
treatment modalities for streptococcus gingivitis 
was used. It can be said that oral antacid treatment 
as well as conventional periodontal treatment may 
be helpful in the treatment of oral infections due 
to Streptococcus.
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